Target intelligence / Profile preview

MicroRNA 3122 (miR-3122)

Target
miR-3122
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 3122 is a human microRNA gene (miRNA), encoded as a non-coding RNA. MicroRNAs such as miR-3122 are short (20–24 nucleotides) RNAs that regulate gene expression post-transcriptionally by targeting mRNAs for degradation or translational repression. The biogenesis involves transcription of a primary microRNA, nuclear processing by Drosha/DGCR8, cytoplasmic processing by Dicer, and incorporation of the mature miRNA into the RNA-induced silencing complex (RISC), which mediates mRNA targeting and silencing. No specific biological function, tissue specificity, molecular interaction, or disease relevance has been functionally annotated for miR-3122 in current gene, RNA, or protein databases.

Other names
hsa-mir-3122mir-3122MIR3122
02

Mechanism of action

Not applicable. No drugs targeting miR-3122 are described, thus no mechanism-of-action information is available.

03

Biological functions

Post-transcriptional gene regulation (inferred for canonical miRNAs)Regulation of mRNA stability and translation (general for miRNAs)Specific direct functions for microRNA 3122 (miR-3122) are not annotated in current databases
04

Disease associations

Currently no disease associations, roles, or specific implications for cancer, inflammation, neurodegeneration, cardiovascular disease, infection, etc. are annotated for miR-3122

Beyond the preview

Go deeper on MicroRNA 3122 (miR-3122).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3122 (miR-3122).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call